insights_auto
Why is ZBIO down 3,15%?
Dive Deeperchevron_right
ZBIO:NASDAQ
Zenas Biopharma Inc
US$26,40
arrow_downward
-3,15%(-0,86) 1D
US$26,40
0,00% (0,00)
bedtimeAfter hours
Closed: 12 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZBIO...
Open
US$26,93
High
US$27,49
Low
US$26,30
Mkt. cap
1,72 ຕື້
Avg. vol.
677,46 ພັນ
Volume
602,49 ພັນ
52-wk high
US$44,54
52-wk low
US$13,50
EPS
US$-8,97
Shares outstanding
65,18 ລ້ານ
No. of employees
167
Open
US$26,93
High
US$27,49
Low
US$26,30
Mkt. cap
1,72 ຕື້
Avg. vol.
677,46 ພັນ
Volume
602,49 ພັນ
52-wk high
US$44,54
52-wk low
US$13,50
EPS
US$-8,97
Shares outstanding
65,18 ລ້ານ
No. of employees
167
News stories
From web sources and news partners
Investing.com Canada
·
16 ຊົ່ວໂມງກ່ອນ
Zenas BioPharma presents extended obexelimab data for IgG4-RD By Investing.com
About Zenas Biopharma Inc
CEO-
Employees167
Founded2019
HeadquartersWaltham, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websitezenasbio.com